Background: Subjects with neurofibromatosis type 1 (NF1) show an increased risk of endocrine tumors, especially pheochromocytoma, whereas thyroid C-cell hyperplasia (CCH) and medullary thyroid carcinoma (MTC) are very rare events described only in adult patients. Method. A case of CCH diagnosed in a 14-year-old girl affected with NF1 is reported. Calcitonin serum level after pentagastin was elevated (286 pg/ml). Genetic testing was performed in order to rule out mutations in the RET protooncogene. Result. No germline mutation previously reported in MEN2 was detected. Multifocal and bilateral CCH was demonstrated by immunohistochemistry. Conclusion: It is suggested that in such a genetic background of high risk for malignancy, CCH could be considered as an extremely rare condition likely preceding MTC. Copyright (C) 2002 S. Karger AG, Basel.

Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1 / Segni, Maria; Massa, Rita; Bonifacio, Vincenzo; Tartaglia, Francesco; Ida, Pucarelli; Antonella, Marzullo; Pasquino, Anna Maria. - In: HORMONE RESEARCH. - ISSN 0301-0163. - STAMPA. - 56:1-2(2001), pp. 63-66. [10.1159/000048092]

Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1

SEGNI, Maria;MASSA, Rita;BONIFACIO, Vincenzo;TARTAGLIA, Francesco;PASQUINO, Anna Maria
2001

Abstract

Background: Subjects with neurofibromatosis type 1 (NF1) show an increased risk of endocrine tumors, especially pheochromocytoma, whereas thyroid C-cell hyperplasia (CCH) and medullary thyroid carcinoma (MTC) are very rare events described only in adult patients. Method. A case of CCH diagnosed in a 14-year-old girl affected with NF1 is reported. Calcitonin serum level after pentagastin was elevated (286 pg/ml). Genetic testing was performed in order to rule out mutations in the RET protooncogene. Result. No germline mutation previously reported in MEN2 was detected. Multifocal and bilateral CCH was demonstrated by immunohistochemistry. Conclusion: It is suggested that in such a genetic background of high risk for malignancy, CCH could be considered as an extremely rare condition likely preceding MTC. Copyright (C) 2002 S. Karger AG, Basel.
2001
c-cell hyperplasia; medullary thyroid carcinoma; neuroendocrine tumors; neurofibromatosis type 1
01 Pubblicazione su rivista::01a Articolo in rivista
Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1 / Segni, Maria; Massa, Rita; Bonifacio, Vincenzo; Tartaglia, Francesco; Ida, Pucarelli; Antonella, Marzullo; Pasquino, Anna Maria. - In: HORMONE RESEARCH. - ISSN 0301-0163. - STAMPA. - 56:1-2(2001), pp. 63-66. [10.1159/000048092]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/253391
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact